On ECHEMI
Home > Drugs > CSPC OUYI Pharmaceutical Co., Ltd.

CSPC OUYI Pharmaceutical Co., Ltd.

  • Founded in:

    2001-03-29
  • Country:

    China China
  • Address:

    No. 88, Yangzi Road, Shijiazhuang Economic and Technological Development Zone
  • Tax NO.:

    91130100601289268L
  • Registered Funds:

    298 million yuan
  • Website:

  • Email:

Related Drugs
Azithromycin for injection
Main ingredients: The main ingredient of this product is azithromycin. Its chemical name is (2R, 3S, 4R, 5R, 8R, 10R, 11R, 12S, 13S, 14R)-13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-beta;-D-xyl-pyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one. Structural formula: (see azithromycin dry suspension) Molecular formula: C38H72N2O12 Molecular weight: 749
Name Description Content CAS NO. Registered Holders
Azithromycin

Azithromycin is a 15-membered macrolide antibiotic. In vitro tests have shown that azithromycin has antibacterial effects on a variety of common clinical pathogens, including: Gram-positive aerobic bacteria, Staphylococcus aureus, Streptococcus pyogenes (group A beta; hemolytic streptococci), pneumonia (streptococci), a-hemolytic streptococci (grass-green streptococci) and other streptococci, diphtheria (rod-shaped) bacilli. This product shows cross-resistance to erythromycin-resistant Gram-positive bacteria, including fecal streptococci (enterococci) and various methicillin-resistant Staphylococcus strains.

More

Azithromycin is a 15-membered macrolide antibiotic. In vitro tests have shown that azithromycin has antibacterial effects on a variety of common clinical pathogens, including: Gram-positive aerobic bacteria, Staphylococcus aureus, Streptococcus pyogenes (group A beta; hemolytic streptococci), pneumonia (streptococci), a-hemolytic streptococci (grass-green streptococci) and other streptococci, diphtheria (rod-shaped) bacilli. This product shows cross-resistance to erythromycin-resistant Gram-positive bacteria, including fecal streptococci (enterococci) and various methicillin-resistant Staphylococcus strains.

83905-01-5 39
Adrenaline hydrazone tablets
The main ingredient of this product is adrenaline.
Name Description Content CAS NO. Registered Holders
Carbazochrome

It is an oxidized derivative of adrenaline and has no adrenaline-mimetic effect, so it does not affect blood pressure and heart rate, but it can enhance the resistance of capillaries to damage, stabilize the acidic mucopolysaccharides in blood vessels and surrounding tissues, reduce the permeability of capillaries, and enhance the retraction effect of damaged capillary ends, making it difficult for blood clots to fall off the tube wall, thereby shortening the hemostasis time, but it does not affect the coagulation process.

More

It is an oxidized derivative of adrenaline and has no adrenaline-mimetic effect, so it does not affect blood pressure and heart rate, but it can enhance the resistance of capillaries to damage, stabilize the acidic mucopolysaccharides in blood vessels and surrounding tissues, reduce the permeability of capillaries, and enhance the retraction effect of damaged capillary ends, making it difficult for blood clots to fall off the tube wall, thereby shortening the hemostasis time, but it does not affect the coagulation process.

69-81-8 4
Children's Trimethoprim-Bis-sulfuron Granules
This product is a compound preparation, its components are: sulfamethoxazole 0.1g, sulfadiazine 0.1g, trimethoprim 40mg.
Name Description Content CAS NO. Registered Holders
Sulfamethoxazole

It acts on dihydrofolate synthase, interferes with the synthesis of folate reductase, and has a synergistic antibacterial effect with trimethoprim, which is stronger than that of a single drug, and reduces the number of strains that are resistant to it.

More

It acts on dihydrofolate synthase, interferes with the synthesis of folate reductase, and has a synergistic antibacterial effect with trimethoprim, which is stronger than that of a single drug, and reduces the number of strains that are resistant to it.

0.1g 723-46-6 33
Sulfadiazine

It acts on dihydrofolate synthase, interferes with the synthesis of folate reductase, and has a synergistic antibacterial effect with trimethoprim, which is stronger than that of a single drug, and reduces the number of strains that are resistant to it.

More

It acts on dihydrofolate synthase, interferes with the synthesis of folate reductase, and has a synergistic antibacterial effect with trimethoprim, which is stronger than that of a single drug, and reduces the number of strains that are resistant to it.

0.1g 68-35-9 14
Trimethoprim

Interferes with the function of synthetic folate reductase, and the synergistic antibacterial effect with sulfamethoxazole and sulfadiazine is stronger than that of single drugs, and the number of strains resistant to them is reduced.

More

Interferes with the function of synthetic folate reductase, and the synergistic antibacterial effect with sulfamethoxazole and sulfadiazine is stronger than that of single drugs, and the number of strains resistant to them is reduced.

40mg 738-70-5 44
Scopolamine Extract Tablets
The main ingredients of this product are: 8 mg of scopolamine extract.
Name Description Content CAS NO. Registered Holders
Scopolamine extract

This product is a peripheral anticholinergic drug. In addition to its spasmolytic effect on smooth muscle, it also has the effect of blocking ganglia and neuromuscular junctions, but its effect on the central nervous system is weak. It can relieve spasms of smooth muscles in the gastrointestinal tract, bile duct and urinary tract and inhibit gastrointestinal peristalsis.

More

This product is a peripheral anticholinergic drug. In addition to its spasmolytic effect on smooth muscle, it also has the effect of blocking ganglia and neuromuscular junctions, but its effect on the central nervous system is weak. It can relieve spasms of smooth muscles in the gastrointestinal tract, bile duct and urinary tract and inhibit gastrointestinal peristalsis.

8mg 0
Azithromycin Capsules
The main ingredient of this product is azithromycin, whose chemical name is (2R, 3S, 4R, 5R, 8R, 10R, 11R, 12S, 13S, 14R)-13-[(2,6-dideoxy-3-C-methyl-3-O-methyl--L-ribopyranosyl)oxy]-2-ethyl-3,
Name Description Content CAS NO. Registered Holders
Azithromycin

It inhibits bacterial protein synthesis by hindering bacterial transpeptidation. It is effective against a variety of Gram-positive aerobic bacteria, Gram-negative aerobic bacteria, anaerobic bacteria, sexually transmitted disease microorganisms and other microorganisms. It can reach high concentrations at the site of infection, and its metabolites have no antibacterial activity.

More

It inhibits bacterial protein synthesis by hindering bacterial transpeptidation. It is effective against a variety of Gram-positive aerobic bacteria, Gram-negative aerobic bacteria, anaerobic bacteria, sexually transmitted disease microorganisms and other microorganisms. It can reach high concentrations at the site of infection, and its metabolites have no antibacterial activity.

83905-01-5 39
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.